UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Trimmed by Paulson Wealth Management Inc.

Paulson Wealth Management Inc. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,601 shares of the healthcare conglomerate’s stock after selling 18 shares during the quarter. Paulson Wealth Management Inc.’s holdings in UnitedHealth Group were worth $1,834,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Signature Resources Capital Management LLC boosted its holdings in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the last quarter. Continuum Advisory LLC increased its holdings in UnitedHealth Group by 0.6% during the 2nd quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock worth $1,737,000 after purchasing an additional 19 shares during the period. Veracity Capital LLC grew its stake in UnitedHealth Group by 1.5% during the 1st quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock worth $660,000 after buying an additional 20 shares during the last quarter. Rodgers Brothers Inc. increased its holdings in shares of UnitedHealth Group by 2.4% during the 1st quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate’s stock valued at $417,000 after purchasing an additional 20 shares in the last quarter. Finally, Aprio Wealth Management LLC increased its stake in shares of UnitedHealth Group by 2.1% in the 2nd quarter. Aprio Wealth Management LLC now owns 975 shares of the healthcare conglomerate’s stock worth $497,000 after acquiring an additional 20 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. TD Cowen increased their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. UBS Group lifted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Barclays lifted their price target on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Wells Fargo & Company raised their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $614.17.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

UNH traded up $2.69 on Monday, hitting $587.20. The company had a trading volume of 1,799,987 shares, compared to its average volume of 4,151,732. The stock has a market cap of $542.23 billion, a price-to-earnings ratio of 35.89, a price-to-earnings-growth ratio of 1.61 and a beta of 0.59. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $592.09. The company’s fifty day moving average price is $537.83 and its 200 day moving average price is $509.89. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the previous year, the firm posted $6.14 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group’s dividend payout ratio is 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.